Orchestra BioMed Holdings, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$14.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$491.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $477.00K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$593.00K, a 211.05% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$139.00K, a 123.56% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$880.00K, a 182.17% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.07M, a 37.13% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $781.00K, a 77.90% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $439.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$491.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$14.00K 10-Q · filed 2026-08-10 | -$607.00K derived: sum of 3 quarters · filed 2026-08-10 | -$746.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $477.00K 10-Q · filed 2026-05-12 | -$116.00K derived: sum of 2 quarters · filed 2026-05-12 | -$255.00K derived: sum of 3 quarters · filed 2026-05-12 | -$368.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$593.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$732.00K derived: sum of 2 quarters · filed 2026-03-12 | -$845.00K derived: sum of 3 quarters · filed 2026-08-10 | -$880.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$252.00K derived: sum of 2 quarters · filed 2026-08-10 | -$287.00K 10-Q · filed 2025-11-10 | $247.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$148.00K 10-Q · filed 2026-08-10 | $386.00K derived: sum of 3 quarters · filed 2026-08-10 | $976.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$35.00K 10-Q · filed 2026-05-12 | $499.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.09M derived: sum of 3 quarters · filed 2026-05-12 | $976.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.12M derived: sum of 2 quarters · filed 2026-03-12 | $1.01M derived: sum of 3 quarters · filed 2026-03-12 | $1.07M 10-K · filed 2026-03-12 |
| 2024-09-30 | $590.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $477.00K derived: sum of 2 quarters · filed 2025-11-10 | $537.00K 10-Q · filed 2025-11-10 | $860.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$53.00K 10-Q · filed 2025-08-12 | $270.00K derived: sum of 3 quarters · filed 2025-08-12 | $5.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $60.00K 10-Q · filed 2025-05-12 | $383.00K derived: sum of 2 quarters · filed 2025-05-12 | $118.00K derived: sum of 3 quarters · filed 2025-05-12 | -$656.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $58.00K derived: sum of 2 quarters · filed 2025-03-31 | -$716.00K derived: sum of 3 quarters · filed 2025-03-31 | $781.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.04M derived: sum of 2 quarters · filed 2024-11-12 | $458.00K 10-Q · filed 2024-11-12 | $422.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$774.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $723.00K 10-Q · filed 2024-08-12 | $687.00K derived: sum of 3 quarters · filed 2024-08-12 | $677.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-13 | $1.46M derived: sum of 2 quarters · filed 2024-05-13 | $1.45M derived: sum of 3 quarters · filed 2024-05-13 | $2.01M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$46.00K derived: sum of 2 quarters · filed 2024-03-27 | $511.00K derived: sum of 3 quarters · filed 2024-03-27 | $439.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $547.00K derived: sum of 2 quarters · filed 2023-11-13 | $475.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $485.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$72.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |